CellaVision Valuation
| CLVSF Stock | USD 15.85 0.40 2.59% |
At this time, the firm appears to be fairly valued. CellaVision AB shows a prevailing Real Value of $16.11 per share. The current price of the firm is $15.85. Our model approximates the value of CellaVision AB from analyzing the firm fundamentals such as Return On Equity of 0.2, shares outstanding of 23.85 M, and Profit Margin of 0.19 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that CellaVision's price fluctuation is very steady at this time. Calculation of the real value of CellaVision AB is based on 3 months time horizon. Increasing CellaVision's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CellaVision pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CellaVision AB. Since CellaVision is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CellaVision Pink Sheet. However, CellaVision's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.85 | Real 16.11 | Hype 15.85 |
The real value of CellaVision Pink Sheet, also known as its intrinsic value, is the underlying worth of CellaVision AB Company, which is reflected in its stock price. It is based on CellaVision's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CellaVision's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CellaVision AB helps investors to forecast how CellaVision pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CellaVision more accurately as focusing exclusively on CellaVision's fundamentals will not take into account other important factors: About CellaVision Valuation
The pink sheet valuation mechanism determines CellaVision's current worth on a weekly basis. Our valuation model uses a comparative analysis of CellaVision. We calculate exposure to CellaVision's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CellaVision's related companies.CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. CellaVision AB was incorporated in 1994 and is headquartered in Lund, Sweden. Cellavision is traded on OTC Exchange in the United States.
8 Steps to conduct CellaVision's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CellaVision's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CellaVision's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CellaVision's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CellaVision's revenue streams: Identify CellaVision's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CellaVision's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CellaVision's growth potential: Evaluate CellaVision's management, business model, and growth potential.
- Determine CellaVision's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CellaVision's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CellaVision Growth Indicators
Investing in growth stocks can be very risky. If the company such as CellaVision does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 23.9 M | |
| Quarterly Earnings Growth Y O Y | -0.185 | |
| Forward Price Earnings | 32.7869 | |
| Retained Earnings | 537.3 M |
Complementary Tools for CellaVision Pink Sheet analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |